Note: Ingredients listed on restricted chemical lists
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
≥90
EC/CAS
231-765-0/7722-84-1
Name of the chemical
Hydrogen peroxide
Concentration
5-8
General Information
Revision date
2022-10-17
Product name
O2 SAFE 7.4
1.2.1 Relevant identified uses
Industrial,Product for professional use
1.2.2. Uses advised against
Title
supplier name
DEVEA SAS
Manufacturer Name
DEVEA SAS
Emergency telephone
00 353 1 8379964, 00 353 1 8092568, +44 20 7188 7188
Icons in SDS
Company Information
company name
DEVEA SAS
e-mail address of the competent person responsible for the Safety Data Sheet
fds@stockmeier.fr
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
Adverse physicochemical, human health and environmental effects
Reacts violently with : Combustibles. Organic compounds. May cause fire/explosion.
2.2 Label elements
Labelling
Hazard pictograms
GHS07
Signal word
Warning
Hazard statements
H319 - Causes serious eye irritation.
Precautionary statements
P264 - Wash hands thoroughly after handling. P280 - Wear protective gloves, protective clothing, eye protection, face protection. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 - If eye irritation persists: Get medical advice/attention. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
